Ilhan Y, Tatli AM, Teker F, Onder AH, et al. Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer. Int J Gynecol Cancer 2022 Jan 27. pii: ijgc-2021-003165.
PMID: 35086927